KRAS and NRAS Mutation Analysis Panel Test
Test Cost: AED 2570.0
Symptoms and Diagnosis
The KRAS and NRAS Mutation Analysis Panel test is a molecular diagnostic test that detects specific mutations in the KRAS and NRAS genes. These genes are commonly mutated in various types of cancer, including colorectal cancer, lung cancer, and melanoma. The test analyzes the DNA from a patient’s tumor sample to identify mutations in the KRAS and NRAS genes. The presence of these mutations can provide important information about the prognosis of the cancer and can help guide treatment decisions.
Test Components
- Price: AED 2570.0
- Sample Condition: Submit formalin fixed paraffin embedded tissue block. Ship at room temperature. Block should have at least 10% tumor tissue.
- Duly filled NGS Test Requisition Form is mandatory.
Report Delivery
Sample: Tuesday by 11 am
Report: Monday
Method
PCR, Fragment analysis, and Sequencing
Test Type
Cancer
Doctor
Oncologist
Test Department
Molecular Diagnostics
Pre Test Information
Duly filled NGS Test Requisition Form is mandatory.
Test Details
The KRAS & NRAS Mutation Analysis Panel test is typically performed on patients with advanced or metastatic cancer, as these mutations are more commonly found in these stages of the disease. The test can help determine if a patient is eligible for targeted therapies that specifically target the mutated KRAS or NRAS proteins. Overall, the KRAS & NRAS Mutation Analysis Panel test is an important tool in personalized medicine, as it helps tailor treatment options to individual patients based on their specific genetic mutations.
Test Name | KRAS and NRAS MUTATION ANALYSIS PANEL Test |
---|---|
Components | |
Price | 2570.0 AED |
Sample Condition | Submit formalin fixed paraffin embedded tissue block. Ship at room temperature. Block should have at least 10% tumor tissue. Duly filled NGS Test Requisition Formis mandatory. |
Report Delivery | Sample Tue by 11 am; Report Mon |
Method | PCR, Fragment analysis and Sequencing |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | Duly filled NGS Test Requisition Formis mandatory. |
Test Details |
The KRAS & NRAS Mutation Analysis Panel test is a molecular diagnostic test that detects specific mutations in the KRAS and NRAS genes. These genes are commonly mutated in various types of cancer, including colorectal cancer, lung cancer, and melanoma. The test analyzes the DNA from a patient’s tumor sample to identify mutations in the KRAS and NRAS genes. The presence of these mutations can provide important information about the prognosis of the cancer and can help guide treatment decisions. The KRAS & NRAS Mutation Analysis Panel test is typically performed on patients with advanced or metastatic cancer, as these mutations are more commonly found in these stages of the disease. The test can help determine if a patient is eligible for targeted therapies that specifically target the mutated KRAS or NRAS proteins. Overall, the KRAS & NRAS Mutation Analysis Panel test is an important tool in personalized medicine, as it helps tailor treatment options to individual patients based on their specific genetic mutations. |